G9063 Onc diagnosis nsclc stgi no progres
Also known as: NSCLC stage 1 diagnosed, early-stage lung cancer no progression
Performance measure documenting diagnosis of Non-Small Cell Lung Cancer (NSCLC) stage I with no evidence of disease progression.
In Plain Language
lung cancer in early stage without spread; stage 1 non-small cell lung cancer
Clinical Context
Quality measure documenting oncology staging of early-stage non-small cell lung cancer for treatment planning.
RVU Information
CPT G9063 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
G-codes are CMS-specific HCPCS codes for services not covered by standard CPT. Documentation requirements follow the same standards as the equivalent CPT service. Check Medicare LCD/NCD policies for coverage criteria.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the G Codes category, 85% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code G9063?
CPT G9063 (Onc diagnosis nsclc stgi no progres) is a G Codes code. Performance measure documenting diagnosis of Non-Small Cell Lung Cancer (NSCLC) stage I with no evidence of disease progression.
Who uses CPT code G9063?
CPT G9063 is used by Thoracic Oncology, Pulmonary Medicine. Quality measure documenting oncology staging of early-stage non-small cell lung cancer for treatment planning.
When is CPT G9063 used?
Quality measure documenting oncology staging of early-stage non-small cell lung cancer for treatment planning.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.